Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China 2019-11-14 23:45
Samsung Biologics Enhances Its Trusted Service as the First and Only ISO27001 Certified CDMO 2019-11-14 20:00
China Biologic Reports Financial Results for the Third Quarter of 2019 2019-11-14 05:43
Akesobio Presents Phase 1 Clinical Data from First-in-class Bispecific Drug Candidate AK104 (PD1/CTLA4) As Oral Presentation, at 2019 SITC Annual Meeting 2019-11-11 17:35
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 20:24
TransThera Biosciences Lead Product TT-00420 Granted Orphan Drug Designation from FDA to Treat Cholangiocarcinoma 2019-11-07 20:08
Polynoma Presenting Interim Phase III Data for Its Investigational Melanoma Vaccine, Seviprotimut-L, at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2019-11-06 20:00
Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830 2019-11-05 08:22
Luye Pharma's LY03004 Manufacturing Facility Successfully Passes U.S. FDA Pre-approval Inspection with Zero Observation 2019-11-05 00:39
China Biologic Products to Report Third Quarter 2019 Financial Results 2019-11-04 21:30
Mallinckrodt and Terumo BCT Announce UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for the Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults 2019-11-01 04:35
GC Pharma Reports Q3 2019 Results 2019-10-30 21:00
Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis 2019-10-28 20:30
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH) 2019-10-26 19:00
Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences 2019-10-26 18:01
World first clinical trial commenced in alcohol use disorder 2019-10-24 12:01
GN Corporation and Edogawa Evolutionary Laboratory of Science Cosponsor International Academic Conference, NCRM NICHE 2019, on October 15, 2019 2019-10-21 14:00
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas 2019-10-18 20:30
China Biologic Special Committee Retains Financial Advisor and Legal Counsel 2019-10-17 20:00
Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH 2019-10-16 18:00
1 130 131 132 133 134 170